MedTrace Logo

Dexmedetomidine vs Midazolam on Resting Energy Expenditure in Critically Ill Patients

NCT03030911 · Status: COMPLETED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 30

Last updated 2018-03-27

No results posted yet for this study

Summary

The aim of this study is to compare the effect of dexmedetomidine on resting energy expenditure in relation to the midazolam in critically ill patients using indirect calorimetry

Conditions

  • Mechanical Ventilation
  • Dexmedetomidine
  • Midazolam
  • Sedation

Interventions

DRUG

Dexmedetomidine

The drug will be administered for sedation and its effect on basal metabolic rate will be investigated

DRUG

Midazolam

The drug will be administered for sedation and its effect on basal metabolic rate will be investigated

DRUG

Fentanyl

The drug will be administered in both groups

DEVICE

Indirect calorimetry

The device will be used for measurement of basal metabolic rate

Sponsors & Collaborators

  • Cairo University

    lead OTHER

Principal Investigators

  • Mohamed Abdulatif, Professor · Professor and member of research committee of anesthesia department

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
TRIPLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2017-01-01
Primary Completion
2018-03-10
Completion
2018-03-15

Countries

  • Egypt

Study Locations

More Related Trials

Entities

Drugs

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03030911 on ClinicalTrials.gov